refers exclusively to the Malayan spitting cobra (was known as Malay cobra at one time). In view of the medical importance of spitting cobras in Southeast Asia, it is important to re-investigate their venom properties. In the present study, the biochemical and toxinological properties of venom from N. sumatrana were examined and compared with the biochemical and toxinological properties of venoms from the other Southeast Asian spitting cobras (N. sputatrix and N. siamensis) as well as N. kaouthia (monocellate cobra) which is also a common cobra in Malaysia. 55 The knowledge of the toxinological properties of these venoms is important in order to understand the pathophysiological of cobra bites in Southeast Asia.
INTRODUCTION
Cobra (Naja sp.) is one of the commonest causes of snake envenomaton in Asia, including Malaysia (Warrell, 1995) . In the last two decades, the systematics of the Asiatic cobra (formerly known as Naja naja) has been revised and many subspecies have been elevated to the status of full species (Wüster, 1996) . A number of cobras have also been appropriately renamed. For example, the spitting cobras of Southeast Asia, once known collectively as Naja sputatrix (formerly known as Malayan cobra) has been divided into three separate species:
Naja siamensis (Indochinese spitting cobra) in Thailand, Naja sumatrana (Equatorial spitting cobra) in Peninsula Malaysia and Sumatra, and Naja sputatrix (Javan spitting cobra) in Java and southern Indonesia.
Despite some early reports on the toxinological properties of the spitting cobra venom in Malaysia, it is not known whether the venom samples used for the investigations labeled as N. sputatrix, were from N. sumatrana or N. sputatrix (Tan, 1991) . This was due to the confusion of the systematics of Southeast Asian spitting cobra prior to earlier 1990's and it was then assumed that N. sputatrix
Phosphodiesterase assay
Phosphodiesterase activity was determined by a method modified from Lo et al. (1966) . The venom solution/fraction (0.1 ml) was added to an assay mixture containing 0.5 ml of 0.0025 M Ca-bis-p-nitrophenyl phosphate, 0.3 ml of 0.01 M magnesium sulfate and 0.5 ml of 0.17 M veronal buffer (sodium barbital), pH 9.0. The reaction was monitored by absorbance measurement at 400 nm.
Phosphodiesterase activity was expressed in nmole of product released/min.
Molar extinction coefficient at 400 nm was 8100 cm -1 M -1 .
Alkaline phosphomonoesterase assay
Alkaline phosphomonoesterase assay was carried out by a method modified from Lo et al. (1966) . A substrate mixture consisting of 0.5 ml of 0.5 M glycine buffer, pH 8.5; 0.5 ml of 0.01 M p-nitrophenylphosphate and 0.3 ml of 0.01 M magnesium sulfate was prepared. The venom solution/fraction (0.1 ml)
was added to the substrate mixture, and incubated at 37°C for 30 min. After 20 min, 2 ml of 0.2 M sodium hydroxide was added, and absorbance at 400 nm was measured. Alkaline phosphomonoesterase activity was expressed as nmole of product released/min. The molar extinction coefficient at 400 nm was 18500 cm -1 M -1 .
5'-Nucleotidase assay
The 5'-nucleotidase activity was measured according to Heppel and Hilmore (1955) . The venom solution/fraction (0.1 ml) was added to an assay mixture containing 0.5 ml of 0.02 M 5'-adenosine monophosphate (pre-adjusted to pH 8.5), 0.5 ml of 0.2 M glycine buffer, pH 8.5 and 0.1 ml of 0.1 M magnesium sulfate. The mixture was incubated at 37°C for 10 min, and the reaction was terminated by adding 1.5 ml of 10% (v/v) trifluoroacetic acid. The quantity of inorganic phosphate released was determined by ascorbic acid method (Chen et al., 1956) . Briefly, 1 ml of ascorbic acid reagent (equal parts of 3 M sulfuric acid, 2.5% (w/v) ammonium molibdate, 10% (w/v) ascorbic acid and UltraPure TM water) was added to the above mixture. The mixture was incubated at room temperature for 30 min. The absorbance at 820 nm was then determined. A standard curve of known phosphate concentrations was constructed. The enzyme activity was expressed as nmole of phosphate/min.
Hyaluronidase assay
Hyaluronidase activity was determined turbidimetrically as described by Dorfman and Ott (1948) . The venom solution/fraction (0.1 ml) was added to an assay mixture containing 1 ml of 0.03% (w/v) hyaluronic acid in 0.3 M sodium phosphate pH 5.35, and 1 ml of 0.02 M sodium phosphate, pH 7.0 containing 0.077 M sodium chloride. The mixture was incubated at 37°C for 45 min.
Subsequently, 2.5 ml of acid albumin reagent (0.024 M sodium acetate, pH 3.75 containing 0.1% (w/v) bovine serum albumin) was added to 0.5 ml of the above reaction mixture and incubated at room temperature for another 10 min.
The absorbance at 600 nm was then measured. A standard curve was constructed using a standard hyaluronidase (760 National Formulary Unit/ mg solid). Hyaluronidase activity was expressed in National Formulary Unit/mg (NFU/mg).
Phospholipase A 2 assay
Phospholipase A 2 activity was determined according to the acidimetric method of Tan and Tan (1988a) . Briefly, an egg yolk suspension was prepared by mixing three equal parts consisting of one part chicken egg yolk, one part 18 mM calcium chloride, and one part 8.1 mM sodium deoxycholate. The pH of the egg yolk suspension was adjusted to 8.0 with 1 M sodium hydroxide, and stirred for 10 min to ensure homogenous mixing. Next, 0.1 ml of venom solution/fraction was added to 15 ml of egg yolk suspension to initiate the hydrolysis. The decrease in pH was measured. A decrease of 1 pH unit corresponds to 133 μmoles of fatty acid released. Enzyme activity was expressed as μmoles of fatty acid released/min.
L-amino acid oxidase assay
L-amino acid oxidase activity was determined using L-leucine as substrate as described by Decker (1977) . Briefly, 50 μl of 0.0075% (w/v) horseradish peroxidase (100 purpurogalin unit/mg) was added to 0.9 ml of 0.2 M triethanolamine buffer, pH 7.6, containing 0.1% (w/v) L-leucine and 0.0075% (w/v) o-dianisidine, and incubated for 3 min at room temperature. Then, 50 μl of venom solution/fraction was added and the increase in absorbance at 436 nm was measured. The molar extinction coefficient was 8.31 x 10 -3 cm -1 M -1 . Lamino acid oxidase activity was expressed as μmole of L-leucine oxidized/min.
Acetylcholinesterase assay
Acetylcholinesterase activity was determined according to the method described by Ellman et al. (1961) . One hundred microliters of venom solution/fraction was added to an assay mixture contained 0.8 ml of 0.025 M sodium phosphate buffer, pH 7.5, 0.05 ml of 0.0125 M acetylthiocholine iodide and 0.05 ml of 6.66 mM dithionitrobenzoate (DTNB) containing 1 mg/ml sodium bicarbonate. The hydrolysis of the substrate was measured by the increase in absorbance at 412 nm. The molar extinction coefficient was 13600 cm -1 M -1 . The enzyme activity was expressed as μmole of product released/min.
Determination of the Median Lethal Dose (LD 50 )
The median lethal dose (LD 50 ) of the venoms and venom fractions obtained from Resource ® S chromatography was determined as described in, Chapter 3, section 3.2.5.
Statistical analysis
LD 50 of the venoms and venom fractions are expressed as means with 95%
confidence Intervals (C.I) and were calculated using the Probit analysis method of Finney (Finney, 1952) . The significance of difference in enzyme activities was determined by one-way analysis of variance (ANOVA), the level of significance was set at p = 0.05. Table 4 .1 and Hyaluronidase (NFU/mg) 28.4 ± 0.9 84.7 ± 3.2 112.6 ± 9.8 31.5 ± 3.9
RESULTS

Fractionation of the
Acetylcholinesterase (μmole/min/mg) 1.59 ± 0.23 6.02 ± 0.30 2.85 ± 0.00 3.77 ± 0.43
Values in parentheses for LD 50 (i.v.) indicated 95% confidence intervals. To determine enzymatic activities, a 1 mg/ml saline venom stock solution was used. All enzymatic activities determinations were carried out in triplicate. µmoles/min/ml, respectively).
It is noteworthy that all three Southeast Asian spitting cobra venoms contained 30-40% of polypeptide cardiotoxins (as shown in Table 4 .3). In contrast, the non-spitting N. kaouthia venom has a rather low cardiotoxin content (18%). Naja kaouthia 8 18 The chromatographic fractionation of the four Southeast Asian cobra venoms also reveals an interesting common feature of the venoms from spitting cobra: the presence of basic phospholipases A 2 , which were not observed in non-spitting cobra, N.kaouthia venom. Basic phospholipases A 2 are known to be involved in many pharmacological actions of cobra venoms including myotoxicity, cytotoxicity, cardiotoxicity and edema inducing activities (Bhat and Gowda, 1989; Das et al., 2011; Fletcher et al., 1982; Mukherjee, 2008 and Yamaguchi et al., 2001) . Besides, the polypeptide cardiotoxin present in a substantial amount in the Southeast Asian spitting cobra venoms. This would suggest that the three spitting cobra venoms may possess similar pathophysiological actions.
DISCUSSION
Resource
On the other hand, N. kaouthia venom did not possess basic phospholipase A 2 and contained a lower amount of polypeptide cardiotoxins, but possessed very 71 high neurotoxin content. This is consistent with the clinical reports that a high percentage of patients of N. kaouthia envenomation in Thailand experienced neurotoxic symptoms (Viravan et al., 1986) .
